Success Metrics

Clinical Success Rate
89.5%

Based on 368 completed trials

Completion Rate
90%(368/411)
Active Trials
26(5%)
Results Posted
39%(142 trials)
Terminated
43(8%)

Phase Distribution

Ph early_phase_1
6
1%
Ph phase_1
92
17%
Ph not_applicable
51
10%
Ph phase_3
122
23%
Ph phase_2
104
20%
Ph phase_4
140
27%

Phase Distribution

98

Early Stage

104

Mid Stage

262

Late Stage

Phase Distribution515 total trials
Early Phase 1First-in-human
6(1.2%)
Phase 1Safety & dosage
92(17.9%)
Phase 2Efficacy & side effects
104(20.2%)
Phase 3Large-scale testing
122(23.7%)
Phase 4Post-market surveillance
140(27.2%)
N/ANon-phased studies
51(9.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

368 of 426 finished

Non-Completion Rate

13.6%

58 ended early

Currently Active

26

trials recruiting

Total Trials

528

all time

Status Distribution
Active(36)
Completed(368)
Terminated(58)
Other(66)

Detailed Status

Completed368
unknown65
Terminated43
Recruiting17
Withdrawn15
Not yet recruiting9

Development Timeline

Analytics

Development Status

Total Trials
528
Active
26
Success Rate
89.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 16 (1.2%)
Phase 192 (17.9%)
Phase 2104 (20.2%)
Phase 3122 (23.7%)
Phase 4140 (27.2%)
N/A51 (9.9%)

Trials by Status

not_yet_recruiting92%
completed36870%
withdrawn153%
active_not_recruiting92%
suspended10%
terminated438%
enrolling_by_invitation10%
recruiting173%
unknown6512%

Recent Activity

Clinical Trials (528)

Showing 20 of 528 trialsScroll for more
NCT07045142Phase 3

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

Recruiting
NCT06372925Phase 4

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Active Not Recruiting
NCT07727681Phase 4

Perioperative Statins to Prevent AFib After Lung Surgery

Recruiting
NCT05404139Phase 2

Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)

Recruiting
NCT07474649Phase 3

A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Not Yet Recruiting
NCT05483010Phase 2

Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

Recruiting
NCT07717788Not Applicable

Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

Completed
NCT03929744Phase 1

A Study of LY3502970 in Healthy Participants

Completed
NCT07042165Phase 4

Treatment of Bile Acid Diarrhoea With Atorvastatin

Recruiting
NCT06686615

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Recruiting
NCT05705804Not Applicable

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Recruiting
NCT07680595Phase 1

Prospective Management of Plaque Instability With Statins and Extra Folic Acid

Recruiting
NCT07668076Phase 2

The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients

Completed
NCT07534592Phase 1

A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Active Not Recruiting
NCT07530289Phase 1

A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)

Completed
NCT07630363Phase 1

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Not Yet Recruiting
NCT04915183Phase 2

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Recruiting
NCT07624604Not Applicable

Evaluation of the Therapeutic Efficacy of Auricular Pellets Combined With Atorvastatin 20mg in Patients With Dyslipidemia and Phlegm-Dampness Syndrome

Not Yet Recruiting
NCT06289504Phase 1

A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight

Completed
NCT07586540Phase 3

Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
528